1. 20 CPD points under the MMC CPD Grading System.
2. 20 CPD points by the Malaysian Nursing Board.
| Time | |
|---|
| 0700-1700 | Registration |
| 0700-0800 | Sunrise Session |
| 0800-0815 | Opening Remarks |
| 0815-0900 | Presidential Lecture |
| 0900-1030 | Concurrent Session 1A:
Asthma 1- Antibody treatment in asthma
– Elisabeth Bel (Netherlands) - Anti-neutrophil treatment in asthma
– Peter Barnes (UK) - Bronchial thermoplasty in asthma
– Gerard Cox (Canada)
|
Concurrent Session 1B:
Chest Imaging- CT for infectious lung diseases
– Abdul Samad Sakijan (Malaysia) - CT for COPD
– Nguyen Van Tho (Vietnam) - CT for rare lung diseases
– Masashi Takahashi (Japan)
| Concurrent Session 1C:
Cell & Molecular Biology- Recent progress of cellular and molecular biology in respiratory diseases
– Takahide Nagase (Japan) - Generation of airway epithelial cells from iPS cells
– Isao Ito (Japan) - Role of microbiomes in lung diseases
– Philips Hansbro (Australia)
|
| 1030-1100 | Coffee Break |
| 1100-1230 | Concurrent Session 2A:
COPD- Non-smoking COPD versus neutrophilic asthma: similarities and differences
– Jorgen Vestbo (UK) - Asthma-COPD overlap syndrome: biomarker, phenotype or endotype-driven treatment
– Diahn-Warng Perng (Taiwan) - Steroid insensitivity and target therapy for COPD: What do we need and where are we now?
– Peter Barnes (UK)
| Concurrent Session 2B:
Clinical Respiratory Medicine 1- Case 1
– Abdul Razak Muttalif (Malaysia) - Case 2
– Sanjeev K Mehta (India) - Case 3
– Sanjay H Chotirmall (Singapore)
| Concurrent Session 2C:
Environmental & Occupational Health & Epidemiology- E-cigarettes – The good, the bad and the ugly
– Hayden McRobbie (New Zealand) - Asbestos ban and asbestosrelated diseases in Asia
– Soon-Hee Jung (Republic of Korea) - Effect of inorganic dust on the lung
– Takashi Nakano (Japan)
|
| 1230-1400 | Lunch |
| 1230-1330 | Heritage meets Innovation in the Management of COPD
(Sponsored by: Boehringer Ingelheim)
– Lim Seong Yong
– Peter MA Calverly | Bronchodilators - A breath of fresh air into the current thinking for COPD
(Sponsored by: Novartis)
– Diahn-Warng Perng
– Klaus Rabe
– Christine Jenkins | Populations to patients: Personalised medicine in COPD
(Sponsored by: GlaxoSmithKline Pharmaceutical)
– Kourtney Davis
– Paul Jones
– Chris Lai |
| 1400-1530 | Concurrent Session 3A:
Lung Cancer 1
- What's new in the next revision of lung cancer staging
– Kwun Fong (Australia) - Molecular testing in advanced NSCLC
– David Chi Leung Lam (Hong Kong) - Management of resistance to EGFRTKIs and ALKinhibitors
– Chong-Kin Liam (Malaysia)
| Concurrent Session 3B:
Respiratory Infection (nonTB)
- Pulmonary aspergillosis
– Sanjay H Chotirmall (Singapore) - Antibiotic resistance in pneumonia Asia Pacific perspective
– YuanLin Song (China) - Pulmonary melioidosis
– Soon-Hin How (Malaysia)
| Concurrent Session 3C:
Respiratory Neurobiology and Sleep 1
- OSA and COPD (Overlap syndrome) in Asians and Western countries
– Patrick Gerard Moral (Philippines) - Obesity hypoventilation syndromes in Asians and Western countries
– Kazuo Chin (Japan) - Recent advances in OSA and sleep Medicine
– Atul Malhotra (USA)/li>
|
| 1530-1600 | Coffee Break |
| 1600-1730 | Concurrent Session 4A:
Lung cancer 2
- Evolving role of immunotherapy for NSCLC
– Ross Andrew Soo (Singapore) - Small cell lung cancer: the evolving role of radiotherapy
– Yoichi Nakanishi (Japan) - Update on Asian lung cancer screening: randomised and nonrandomised studies
– David Chi Leung Lam (Hong Kong)
| Concurrent Session 4B:
Interstitial Lung Disease 1
-
Difficult-to-diagnose interstitial lung disease: the role of the multidisciplinary team
– John Simpson (UK) - The role of CT scan in interstitial lung diseases
– Masashi Takahashi (Japan) - Advances in the treatment of IPF
– Takashi Ogura (Japan)
| Concurrent Session 4C:
Pleural Diseases
- Unusual pleural diseases
– Anantham Devanand (Singapore) - Management of complicated parapneumonic effusion and empyema thoracis
– Pyng Lee (Singapore) - Current management of malignant mesothelioma
– Agasthian Thirugnanam (Singapore)
|
| 1730-1900 | New perspectives for mucoactive drugs in COPD treatment: The RESTORE study
(Sponsored by Recipharm / Edmond Pharma)
– Roberto W Dal Negro | Asthma and COPD Overlap Syndrome (ACOS) – An India Perspective
(Sponsored by: Cipla Malaysia Sdn Bhd / Cipla Limited)
– Harjit Dumra | |
| 1930-2130 | Faculty Dinner (By Invitation only) |
1. 20 CPD points under the MMC CPD Grading System.
2. 20 CPD points by the Malaysian Nursing Board.
| Time | |
|---|
| 0700-1700 | Registration |
| 0700-0800 | Sunrise Session |
| 0815-0900 | Memorial Lecture: Michiyoshi Harasawa Research Award |
| 0900-1030 | Concurrent Session 5A:
Respiratory Neurobiology and Sleep 2- The upper airway function in OSA
– Peter Eastwood (Australia) - Relationship between OSA and gastroesophageal reflux
– Patrick Gerard Moral (Philippines) - Cerebrocardiovascular diseases in the Korean OSA cohort study
– Chol Shin (the
Republic of Korea)
| Concurrent Session 5B:
Paediatric Lung Diseases 1- Acute management of childhood asthma – an update
– Albert Li (Hong Kong) - Is intermittent use of inhaled corticosteroids a feasible option in children?
– Anne Goh (Singapore) - Longer term outcome of childhood asthma – what do the longitudinal studies tell us
– Peter Le Souef (Australia)
| Concurrent Session 5C:
Bronchoscopy & Interventional Pulmonology- Bronchoscopic lung volume reduction: What's the current status?
– Lonny Yarmus (USA) - Dealing with granulation tissue post-stenting. Any solution?
– Philip Eng (Singapore) - Bronchoscopic management of tracheobronchomalacia / EDAC
– Jamsak Tscheikuna (Thailand)
|
| 1030-1100 | Coffee Break |
| 1100-1230 | Concurrent Session 6A:
Asthma 2- Identifying therapeutic phenotypes of severe asthma
– Kittipong Maneechotesuwan (Thailand) - What are the current and future treatment options for refractory asthma?
– Omar Sharif Usmani (UK) - Poorly controlled asthma in pregnancy: What can we use?
– Dave Singh (UK)
| Concurrent Session 6B:
Paediatric Lung Diseases 2- Update and controversies in the management of childhood pneumonia
– Anne Chang (Australia) - Viruses in paediatric respiratory disease
– Peter Le Souef (Australia) - Bronchiectasis: is it a reversible disease?
– Anne Chang (Australia)
| Concurrent Session 6C:
Pulmonary circulation 1- Screening and diagnosis of pulmonary hypertension
– Aizai Azan Abd Rahim (Malaysia) - Mechanism and management of hypoxiainduced pulmonary hypertension
– Talant Sooronbaev (Kyrgyzstan) - Novel therapy for acute pulmonary embolism
– Heng-Joo Ng (Singapore)
|
| 1230-1400 | Lunch |
| 1230-1330 | Beyond ICS/LABA: The Role of Tiotropium Respimat in Asthma
(Sponsored by: Boehringer Ingelheim)
– Nicola Hanania
– Dina Diaz | Conversations in IgEmediated severe asthma – Past, present and future
(Sponsored by Novartis)
– TseWen Chang
– Jo Douglass
– David Price | The Key Role of Small Airways in Asthma and COPD
(Sponsored by Chiesi and Orient EuroPharma)
– Dave Singh
– Pang Yong Kek |
| 1400-1530 | Concurrent Session 7A:
Young Investigator Session 2 | Concurrent Session 7B:
Clinical Allergy & Immunology- Epithelial biology in the pathogenesis of airway inflammation
– Yasuhiro Gon (Japan) - Recent advances in the pathogenesis of asthma
– Elisabeth Bel (Netherlands) - The lung's response to air pollution
– Ian Yang (Australia)
| Concurrent Session 7C:
Pulmonary circulation 2- The journey to PAH and PHrelated respiratory diseases
– Hiroshi Kimura (Japan) - Treatment update on CTEPH
– Nobuhiro Tanabe (Japan) - Treatment update on PAH
– Masayuki Hanaoka (Japan)
|
| 1530-1600 | Coffee Break |
| 1600-1700 | The Great Debate
Inhaled corticosteroids has a limited role in the management of COPD |
| 1700-1730 | Coffee Break |
| 1730-1830 | Exploring the bronchial tree in asthma: Probing deep into the small airways
(Sponsored by Mundipharma)
– Omar S Usmani
– Chul-Gyu Yoo | Treating the underlying inflammation to achieve asthma control
(Sponsored by AstraZeneca)
– Christine Jenkins | |
| 1900-2100 | Gala Dinner |
1. 20 CPD points under the MMC CPD Grading System.
2. 20 CPD points by the Malaysian Nursing Board.
| Time | |
|---|
| 0700-1700 | Registration |
| 0700-0800 | Sunrise Session |
| 0815-0900 | Memorial Lecture: Ann Janet Woolcock Research Award |
| 0900-1030 | Concurrent Session 8A:
Tuberculosis 1- TB in Asia Pacific
– Nobuyuki Nishikiori (WHO West Pacific Region) - Public-Private Mix in TB Control: Critical appraisal of global evidence and local applications
– Charles Yu (Philippines) - TB and migrants
– Nobuyuki Nishikiori (WHO West Pacific Region)
| Concurrent Session 8B:
Respiratory Structure & Function- Role of handheld spirometer in the screening, diagnosis and monitoring of airflow limitation
– Le Thi Tuyet Lan (Vietnam) - Diffusion capacity – pitfalls and interpretation
– Peter Eastwood (Australia) - Tips and tricks to achieve best lung deposition with different inhaler devices
– Yuko Komase (Japan)
| Concurrent Session 8C: Clinical Respiratory Medicine 2 (Late-breaker Session)- Epidemiology and clinical data of MERSCoV in Republic of Korea
– David ShuCheong Hui (Hong Kong) - From SARS to MERS lessons learned?
– David ShuCheong Hui (Hong Kong) - Emerging Infections: How can we improve preparedness?
– Leo LitMan Poon (Hong Kong)
|
| 1030-1100 | Coffee Break |
| 1100-1200 | Idiopathic Pulmonary Fibrosis Recent perspective and future challenges
(Sponsored by Boehringer Ingelheim)
– Ganesh Raghu
– Dong Soon Kim
– Ulrich Costabel | Pneumonia Prevention in Adults: Current Perspectives
(Sponsored by Pfizer)
– Rontgene Solante
– Abdul Razak Bin Abdul Muttalif | |
| 1200-1330 | Concurrent Session 9A:
Tuberculosis 2- New TB diagnostic tests
– Somsak Rienthong
(Thailand) - Challenges of MDR TB management
– Harjit Dumra (India) - Diagnosis and treatment dilemma of nontuberculous mycobacterial infection
– Erlina Burhan (Indonesia)
| Concurrent Session 9B:
Interstitial Lung Diseases 2- Prevalence and incidence of ILD in the AsiaPacific region
– Yoshikazu Inoue (Japan) - Pathogenesis, diagnosis and treatment of coexisting emphysema and ILD
– Masahito Ebina (Japan) - The ABC of hypersensitivity pneumonitis from the acute to chronic stages
– Tengku Saifudin Tengku Ismail (Malaysia)
| Concurrent Session 9C:
Critical Care Medicine- Diagnosis of ventilatoracquired pneumonia difficult but doable
– John Simpson (UK) - ECMO Extracorporeal Membrane Oxygenation in ARDS
– Yoshiki Ishii (Japan) - Early mobilisation of the ventilated patient: evidence to practice
– LiLing Tai (Malaysia)
|
| 1330-1400 | Closing |
home
